vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and VOX ROYALTY CORP. (VOXR). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $9.3M, roughly 1.6× VOX ROYALTY CORP.). Over the past eight quarters, VOX ROYALTY CORP.'s revenue compounded faster (26.4% CAGR vs 11.9%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Vox Royalty Corp. is a specialized mining royalty and streaming company that provides upfront capital to mining project owners and operators, in exchange for a share of future commodity production revenue or physical output. Its portfolio includes gold, silver, copper and other critical minerals, with core operating markets spanning North America, Australia and Africa, catering to the global mining exploration and development sector.

IRIX vs VOXR — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.6× larger
IRIX
$14.7M
$9.3M
VOXR
Faster 2-yr revenue CAGR
VOXR
VOXR
Annualised
VOXR
26.4%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IRIX
IRIX
VOXR
VOXR
Revenue
$14.7M
$9.3M
Net Profit
$-682.6K
Gross Margin
37.2%
69.2%
Operating Margin
11.8%
Net Margin
-7.4%
Revenue YoY
-69.7%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
VOXR
VOXR
Q4 25
$14.7M
Q3 25
$12.5M
$9.3M
Q2 25
$13.6M
$5.4M
Q1 25
$11.9M
$2.7M
Q4 24
$12.7M
Q3 24
$11.6M
$8.2M
Q2 24
$12.6M
$5.7M
Q1 24
$11.8M
$2.9M
Net Profit
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
$-1.6M
$-682.6K
Q2 25
$-994.0K
$-575.0K
Q1 25
$-1.7M
$-241.4K
Q4 24
$-834.0K
Q3 24
$-1.9M
$316.9K
Q2 24
$-2.7M
$-729.7K
Q1 24
$-3.5M
$-681.2K
Gross Margin
IRIX
IRIX
VOXR
VOXR
Q4 25
37.2%
Q3 25
32.1%
69.2%
Q2 25
34.5%
83.0%
Q1 25
42.5%
90.1%
Q4 24
44.0%
Q3 24
37.3%
97.0%
Q2 24
40.7%
83.8%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
-11.3%
11.8%
Q2 25
-6.9%
15.0%
Q1 25
-1.7%
22.8%
Q4 24
-3.9%
Q3 24
-16.1%
28.5%
Q2 24
-20.9%
7.4%
Q1 24
-28.0%
32.7%
Net Margin
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
-12.6%
-7.4%
Q2 25
-7.3%
-10.6%
Q1 25
-14.2%
-9.0%
Q4 24
-6.6%
Q3 24
-16.7%
3.9%
Q2 24
-21.2%
-12.8%
Q1 24
-29.5%
-23.6%
EPS (diluted)
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
VOXR
VOXR
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
Total Assets
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
VOXR
VOXR
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
$4.7M
Q2 25
$6.1M
Q1 25
$852.0K
Q4 24
$2.1M
Q3 24
$2.6M
Q2 24
$4.2M
Q1 24
$6.5M
Total Assets
IRIX
IRIX
VOXR
VOXR
Q4 25
$29.2M
Q3 25
$28.4M
Q2 25
$31.6M
Q1 25
$34.2M
Q4 24
$29.1M
Q3 24
$30.2M
Q2 24
$31.2M
Q1 24
$34.1M
Debt / Equity
IRIX
IRIX
VOXR
VOXR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRIX
IRIX

Segment breakdown not available.

VOXR
VOXR

Total$8.2M88%
Other$1.1M12%

Related Comparisons